Ubs Global Asset Management Americas »

Deciphera Pharmaceuticals shares owned by Ubs Global Asset Management Americas

Quarter-by-quarter ownership of Deciphera Pharmaceuticals (DCPH) shares owned by Ubs Global Asset Management Americas from 13F filings

Historical chart of Ubs Global Asset Management Americas investment in Deciphera Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Deciphera Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Deciphera Pharmaceuticals by Ubs Global Asset Management Americas

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.5M 400k 16.13
2023-09-30 $5.1M 403k 12.72
2023-06-30 $6.4M 416k 15.45
2023-03-31 $6.4M 416k 15.45
2022-12-31 $589k 36k 16.39
2022-09-30 $974k 53k 18.50
2022-06-30 $664k 51k 13.15
2022-03-31 $414k 45k 9.27
2021-12-31 $437k 45k 9.77
2021-09-30 $12M 358k 33.98
2021-06-30 $14M 393k 36.61
2021-03-31 $13M 286k 44.84
2020-12-31 $15M 283k 51.30
2020-09-30 $15M 283k 51.30
2020-06-30 $16M 271k 59.72
2020-03-31 $12M 283k 41.17
2019-12-31 $19M 312k 62.24
2019-09-30 $7.7M 227k 33.94